Irinotecan and capecitabine as second-line treatment after failure for first-line infusional 24-h 5-fluorouracil/folinic acid in advanced colorectal cancer: a phase II study - Hofheinz, Ralf-Dieter; Gnad-Vogt, Ulrike; Wein, Axel; Saußele, Susanne; Kreil, Sebastian; Pilz, Lothar R.; Hehlmann, Rüdiger; Hochhaus, Andreas (Anti-cancer drugs, 2005)
Gesehen am 12.05.2022